Pacific Fertility Center

Pacific Fertility Center is a reproductive health clinic in San Francisco, specializing in advanced fertility treatments like IVF, IUI, and egg donation, utilizing innovative technologies to meet diverse family-building needs. Founded in 1999, Pacific Fertility Center operates in San Francisco, US, providing advanced reproductive health services. The clinic was acquired by Prelude Fertility, a portfolio company of Lee Equity Partners, in September 2017. Kat Stillman serves as the CEO, steering the company towards innovation in fertility treatments.

Pacific Fertility Center® specializes in comprehensive reproductive health services, primarily focusing on advanced fertility treatments such as in vitro fertilization (IVF), artificial intrauterine insemination (IUI), egg freezing, and egg donation. The clinic employs technology and methodologies to cater to diverse family-building needs. Their offerings address various reproductive conditions, including endometriosis and PCOS, supporting individuals and couples, particularly those over 40 and members of the LGBTQ+ community, in their journey to parenthood. Pacific Fertility Center serves clients across various geographical markets, including Northern California and broader regions, ensuring accessibility for patients from surrounding areas such as Berkeley, Oakland, Palo Alto, and Marin County, as well as beyond.

Revenue generation at Pacific Fertility Center is structured around direct-to-consumer transactions for its specialized fertility services. Clients engage with the clinic for tailored treatment plans, including one-time procedures like IVF or ongoing services such as egg freezing and fertility evaluations. The clinic operates on a fee-for-service model, allowing patients to pay for individual treatments or comprehensive care packages. These offerings target individuals and couples overcoming fertility challenges, contributing to strong demand and consistent client engagement within the fertility care market.

Future growth plans at Pacific Fertility Center include potential new product offerings, although specific details and launch dates are not currently available. The clinic may consider expanding its services to additional markets beyond Northern California, aiming to enhance accessibility for a wider client base. Following the acquisition by Prelude Fertility in September 2017, the clinic is likely leveraging support from its parent company to enhance operational capabilities and drive growth initiatives.